MULTIPLE IMMUNOPEROXIDASE MARKERS IN BENIGN HYPERPLASIA AND ADENOCARCINOMA OF THE PROSTATE

被引：86

作者：

ELLIS, DW ^{[1
]}

LEFFERS, S ^{[1
]}

DAVIES, JS ^{[1
]}

NG, ABP ^{[1
]}

机构：

[1] ROYAL PRINCE ALFRED HOSP,DEPT ANAT PATHOL,SYDNEY,AUSTRALIA

来源：

关键词：

D O I：

10.1093/ajcp/81.3.279

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：279 / 284

页数：6

共 20 条

[1] BENTZ MS, 1982, UROLOGY, V6, P584
[2] BRAUN PN, 1982, CANCER, V49, P525
[3] BURNS J, 1977, BIOMED EXPRESS, V27, P7
[4] FISHLEDER A, 1982, AM J CLIN PATHOL, V77, P648
[5] PREDICTION OF PROGNOSIS FOR PROSTATIC ADENOCARCINOMA BY COMBINED HISTOLOGICAL GRADING AND CLINICAL STAGING
GLEASON, DF
MELLINGE.GT
[J]. JOURNAL OF UROLOGY, 1974, 111 (01) : 58 - 64
[6] SHORTER IMMUNOPEROXIDASE TECHNIQUE FOR DEMONSTRATION OF CARCINOEMBRYONIC ANTIGEN AND OTHER CELL PRODUCTS
HEYDERMAN, E
NEVILLE, AM
[J]. JOURNAL OF CLINICAL PATHOLOGY, 1977, 30 (02) : 138 - 140
[7] JOBSIS AC, 1978, CANCER, V41, P1788, DOI 10.1002/1097-0142(197805)41:5<1788::AID-CNCR2820410521>3.0.CO
[8] 2-D
[9] KURIYAMA M, 1982, J NATL CANCER I, V68, P99
[10] LI CY, 1980, CANCER, V46, P706, DOI 10.1002/1097-0142(19800815)46:4<706::AID-CNCR2820460412>3.0.CO